PHM 492-Pharmacotherapy of Human Viral Infections*
Fall, Spring of every year, starting Fall 2018.
PHM492 is an integrated and multidisciplinary online course that outlines general disease characteristics and clinical presentation (signs and symptoms), essentials of diagnosis, pathophysiology, laboratory features, complications, pharmacotherapeutic options, and disease prevention. This course is designed to provide the course participants with a comprehensive understanding of most common human viral infections and their management strategies with emphasis in pharmacologic approaches.
- Human viral infections: types, immune response, and life cycle.
- Human herpes viruses
- Major vaccine-preventable viral infections
- Neurotropic viruses
- Viral hemorrhagic fevers
- Systemic viral diseases
- Common viral respiratory diseases
- Viral gastroenteritis
- Viral hepatitis
- None Required
Dr. Reza Nassiri
served as Associate Dean of Global Health and Director of Institute of International Health at MSUCOM. He is currently a faculty member at the Departments of Pharmacology and Toxicology and Family and Community Medicine. His teaching expertise includes the pharmacology of infectious diseases and tropical medicine. Scholarly activities include global health issues in the context of infectious diseases, tropical diseases, and public health. His research interests are biochemical pharmacology of antiviral agents, antibiotic resistance, One Health, HIV/AIDS, and viral hepatitis.
Online Summer semester only
- Undergraduate Minor
- MS/Pharmacology & Toxicology
- MS/Integrative Pharmacology
PHM350, PHM 461 or concurrently, Microbiology and physiology.